Intestinal Research

IBD
Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education: Seulji Kim, Seong-Joon Koh; Intest Res. 2022;20(4):389-391. Published online October 28, 2022; DOI: https://doi.org/10.5217/ir.2022.00117
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Miscellaneous
Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies: Priscila A. Lima, Bárbara B. Berg, Marina Gomes Miranda e Castor; Intest Res. 2022;20(4):392-417. Published online May 31, 2022; DOI: https://doi.org/10.5217/ir.2021.00160; Full text PubReader ePub Crossref - TDM PDF

IBD
Natural history of inflammatory bowel disease: a comparison between the East and the West: Eun Mi Song, Suk-Kyun Yang; Intest Res. 2022;20(4):418-430. Published online December 2, 2021; DOI: https://doi.org/10.5217/ir.2021.00104
Cited By 18; Full text PubReader ePub Crossref - TDM PDF

Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements: Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung; Intest Res. 2022;20(4):431-444. Published online January 5, 2022; DOI: https://doi.org/10.5217/ir.2021.00111
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Efficacy of hepatitis B vaccination in patients with ulcerative colitis: a prospective cohort study: Anurag Mishra, Amarender Singh Puri, Sanjeev Sachdeva, Ashok Dalal; Intest Res. 2022;20(4):445-451. Published online February 8, 2022; DOI: https://doi.org/10.5217/ir.2021.00106
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study: Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park; Intest Res. 2022;20(4):452-463. Published online March 11, 2022; DOI: https://doi.org/10.5217/ir.2021.00125
Cited By 2; Full text PubReader ePub Crossref - TDM PDF Supplementary Material Graphic abstract

Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies: Haruka Otake, Satohiro Matsumoto, Hirosato Mashima; Intest Res. 2022;20(4):464-474. Published online March 31, 2022; DOI: https://doi.org/10.5217/ir.2021.00139
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study: Masaaki Usami, Ichiro Takeuchi, Reiko Kyodo, Yuri Hirano, Kosuke Kashiwagi, Hiroki Fujikawa, Hirotaka Shimizu, Toshinao Kawai, Katsuhiro Arai; Intest Res. 2022;20(4):475-481. Published online June 13, 2022; DOI: https://doi.org/10.5217/ir.2021.00142; Full text PubReader ePub Crossref - TDM PDF

Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis: Jong Yop Pae, Eun Soo Kim, Sung Kook Kim, Min Kyu Jung, Jun Heo, Jang Hoon Lee, Min Ae Park; Intest Res. 2022;20(4):482-494. Published online April 15, 2022; DOI: https://doi.org/10.5217/ir.2021.00161; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

IBD
Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use protect from chronic inflammation-induced atherosclerosis?: Aikaterini Mantaka, Nikolaos Galanakis, Dimitrios Tsetis, Ioannis E. Koutroubakis; Intest Res. 2022;20(4):495-505. Published online August 8, 2022; DOI: https://doi.org/10.5217/ir.2022.00017
Cited By 3; Full text PubReader ePub Crossref - TDM PDF

Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care: Alex Barnes, David Carter, Patricia Kaazan, Alissa Walsh, Susan Connor, Jane M Andrews; Intest Res. 2022;20(4):506-508. Published online April 26, 2022; DOI: https://doi.org/10.5217/ir.2022.00003; Full text PubReader ePub Crossref - TDM PDF

Urinary chitinase 3-like 1 and intestinal fatty-acid binding proteins are not elevated in children with inflammatory bowel disease: Shaun Siong Chung Ho, Jacqueline Ilene Keenan, Andrew Stewart Day; Intest Res. 2022;20(4):509-513. Published online July 22, 2022; DOI: https://doi.org/10.5217/ir.2022.00064; Full text PubReader ePub Crossref - TDM PDF

Previous issues